Cancer Patients with Neuropathic Pain: Pharmacist-Led Recommendation and Management and Mirogabalin Outcomes in a Single-Center Retrospective Observational Cohort - PubMed
4 hours ago
- #neuropathic pain
- #mirogabalin
- #pharmacist-led management
- The study evaluated pharmacist-led recommendation and management for mirogabalin in cancer-related neuropathic pain.
- In the per-protocol analysis, subjective effectiveness was 100% in the pharmacist-led group versus 69.2% in the usual-care group (p=0.027).
- A conservative sensitivity analysis showed a consistent trend but was not statistically significant.
- Adverse event-related discontinuation rates were similar between groups (5.6% vs 11.9%, p=0.677).
- Findings suggest pharmacist involvement may improve mirogabalin outcomes and support prospective evaluation.